Cantel Medical (CMN) 44.28 $CMN
Cantel Medical Subsidiary Mar Cor Purification Releases New & Improved MINNCARE DRY FOG® 2 Cleanroom Bio-Decontamination System
PR Newswire - Wed Feb 04, 12:46PM CST
Mar Cor Purification, Inc. (Mar Cor), a subsidiary of Cantel Medical Corp. (NYSE: CMN) has launched a new aerosol-based bio-decontamination system, the MINNCARE DRY FOG® 2, the latest evolution of Mar Cor's Dry Fog Technology and an integral part of modern clean room disinfection procedures. Aimed specifically at the cleanroom industry, the new and improved system is designed completely of 316 L stainless steel and features a robust construction that is engineered to be durable and virtually maintenance free. The new design also features a multi-directional spray apparatus that allows for eight different nozzle(s) positions increasing the coverage possibilities for higher flexibility.
CMN: 44.28 (+1.09)
Cantel Medical's MINNCARE HD Disinfectant Wins FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 1:10PM CST
Mar Cor Purification, Inc., a subsidiary of Cantel Medical Corp. (CMN), recently received approval from the FDA for its MINNCARE HD high level disinfectant
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), CMN: 44.28 (+1.09), SURG: 4.44 (-0.02)
Sterilization Technologies - A 2015 Global Market Overview of the $9.5 Billion Market
M2 - Wed Jan 21, 5:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/4j5x5l/sterilization) has announced the addition of the "Sterilization Technologies - A Global Market Overview" report to their offering. Global sterilization market is expected to touch US$5.3 billion 2015 and projected to touch US$9.5 billion in 2020, growing by a CAGR of 12% between 2014 and 2020. Filtration estimated the leading technology for sterilization in 2014 with US$2.7 billion and expected to touch US$3.1 billion 2015 while Medical Devices is the largest application area with market worth US$3 billion in 2014. Growing and aging global population has led to more and more surgeries being performed today than ever before. Therefore, maintaining patient safety assumes extreme criticality in the field of surgery and rules and regulations have to be in place for every aspect of the process for ensuring that errors are averted at all costs. As a consequence, disinfection and sterilization of surgical instruments becomes one area of crucial significance for upholding patient safety. This factor has a direct correlation with an increase in demand for sterilization equipment. Given the fact that every hospital and healthcare facility gives paramount importance to patient safety, sterilization techniques are most widely utilized for medical device applications. This report reviews, analyses and projects the Sterilization technologies market for global and the regional markets including the United States, Europe, Asia-Pacific and Rest of World. Global market for sterilization technologies is projected to touch $9.5 billion by 2020 growing at a decent rate compounded annually at 12% for the period 2014-2020. The United States leads the global market with a share of 29% closely followed by Europe with 27%, during 2014-2020, converting to US$1.4 billion and 1.3 billion respectively in 2014. Worldwide market for sterilization technologies explored in this study includes Chemical Sterilization, Heat Sterilization, Filtration Sterilization and Radiation Sterilization. The report also analyzes the market by application comprising Medical Devices, Pharmaceuticals, Life Sciences and Others. The global market for the above mentioned technologies and applications is analyzed in terms of USD. Key Topics Covered: Part A: Global Market Perspective 1. Introduction 2. Sterilization Applications - A Snapshot 3. Key Market Trends 4. Key Global Players 5. Key Business Trends 6. Global Market Overview Part B: Regional Market Perspective Regional Market Overview 1. The United States 2. Europe 3. Asia-Pacific 4. Rest Of World Part C: Guide To The Industry 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part
Annexure 1. Research Methodology 2. Feedback Executive Summary: - 3M Company - Advanced Sterilization Products - Andersen Products, Inc. - Baumer SA - Belimed AG - Cantel Medical Corp. - Getinge AB - Medline Industries, Inc - Nordion, Inc. - Sakura Seiki Co Ltd - Sterigenics International Inc. - Sterile Technologies, Inc. - Steris Corporation - Synergy Health Plc - TSO3 Inc. - Tuttnauer USA Co Ltd For more information visit http://www.researchandmarkets.com/research/4j...rilization
MMM: 165.94 (+0.03), NDZ: 12.99 (-0.01), CMN: 44.28 (+1.09)
Love Of Pets, Trips To Vets Lift Idexx Laboratories
at Investor's Business Daily - Thu Jan 15, 5:41PM CST
Francis Pulizzi wouldn't think of scrimping on his pets' health care, even if it's a bit pricey. The New York City native and owner of three Chihuahuas figures that he spends a minimum of $300 each time he takes one of the dogs to the veterinarian. A...
ISRG: 510.73 (+3.02), STE: 65.50 (-0.35), IDXX: 159.08 (+1.72), CMN: 44.28 (+1.09)
Cantel Medical Subsidiary Mar Cor Purification Given 510(k) Clearance For MINNCARE® HD Disinfectant For Use In Water System Disinfection In Kidney Dialysis Applications
PR Newswire - Thu Jan 15, 3:16PM CST
Mar Cor Purification, Inc. (Mar Cor), a subsidiary of Cantel Medical Corp. (NYSE:CMN) announced today that it has been given 510(k) clearance (K133724) from the FDA for MINNCARE® HD high level disinfectant, the first water system disinfectant granted a medical device clearance for use in hemodialysis applications. MINNCARE HD disinfectant is a proprietary blend of peracetic acid and hydrogen peroxide and is completely biodegradable allowing for easy disposal and reducing environmental impact. The non-medical device version, MINNCARE® Cold Sterilant, is considered the gold standard in water system disinfection and is used daily in a variety of markets and applications.
CMN: 44.28 (+1.09)
Cantel Medical on a Buyout Spree, Adds Pure Water Solutions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 07, 1:10PM CST
Cantel Medical Corp (CMN) recently acquired water purification and treatment service provider Pure Water Solutions for $11.9 million in cash.
FMS: 36.43 (-0.65), CMN: 44.28 (+1.09), XRAY: 52.74 (+0.32), ECL: 111.62 (+0.85)
Cantel Medical To Present At The 33rd Annual J.P. Morgan Healthcare Conference
PR Newswire - Tue Jan 06, 10:00AM CST
CANTEL MEDICAL CORP. (NYSE:CMN) announced today that Andrew A. Krakauer, Chief Executive Officer, will be presenting at the 33rd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. The formal presentation is scheduled for Thursday, January 15, 2015 at 8:00 AM Pacific Time (11:00 AM Eastern Time). In addition, Mr. Krakauer, Jorgen B. Hansen, President and COO, and Seth Yellin, Senior Vice President-Corporate Development, will be available for separate one-on-one meetings during the day.
JPM: 59.67 (+0.10), CMN: 44.28 (+1.09)
In the Spotlight: New Research on Intel, Cantel, JPMorgan, American Airlines and Monsanto
PR Newswire - Mon Jan 05, 8:00AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Intel (NASDAQ: INTC), Cantel (NYSE: CMN), JPMorgan (NYSE: JPM), American Airlines (NASDAQ: AAL), and Monsanto (NYSE: MON). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
MON: 124.77 (+2.00), JPM: 59.67 (+0.10), AAL: 48.39 (+0.51), INTC: 34.36 (+0.23), CMN: 44.28 (+1.09)
Cantel Medical reports purchase of Pure Water Solutions for USD11.9m
M2 - Mon Jan 05, 6:18AM CST
Infection prevention company Cantel Medical (NYSE:CMN) said on Friday that it has acquired the assets of Pure Water Solutions for a purchase price of USD11.9m in cash.
CMN: 44.28 (+1.09)
Update: Cantel Medical Acquires Pure Water Solutions
David Zanoni - at Seeking Alpha - Sun Jan 04, 1:51AM CST
CMN: 44.28 (+1.09)
11 Best Mid-Cap Health Care Stocks Worth Targeting for 2015
at The Street - Fri Jan 02, 1:43PM CST
Which mid-cap health care companies should you target for the best returns? Click through to see which stocks are top-rated.
ACHC: 63.20 (-0.45), SIRO: 91.06 (+0.18), WST: 51.35 (+0.57), USPH: 41.08 (+0.07), ATRI: 332.77 (-2.85), STE: 65.50 (-0.35), GB: 50.86 (+0.20), TFX: 112.07 (+0.47), ICLR: 60.01 (+0.38), CMN: 44.28 (+1.09), UTMD: 58.02 (-0.40)
Cantel Med buys water purification and treatment firm
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 8:40AM CST
CMN: 44.28 (+1.09)
Cantel Medical Acquires Pure Water Solutions, Inc.
PR Newswire - Fri Jan 02, 7:30AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) today announced that it acquired the assets of Pure Water Solutions, Inc. for a purchase price of $11.9 million in cash consideration. Headquartered in Ridgeland, Mississippi, Pure Water Solutions provides water purification and treatment services for commercial and industrial, laboratory and medical customers out of eight regional offices throughout the Southeastern United States. The company had pre-acquisition unaudited revenues and EBITDA of just over $8 million and $2 million, respectively, for the trailing twelve months. This transaction is expected to be neutral to Cantel's GAAP EPS in FY15 and slightly accretive to its non-GAAP1 EPS in FY15, and is expected to be accretive on both a GAAP and non-GAAP[1] basis thereafter.
CMN: 44.28 (+1.09)
Cantel Medical - Great Prospects And Track Record, As The Valuation Becomes Too Steep
The Value Investor - at Seeking Alpha - Thu Jan 01, 10:10AM CST
BCR: 175.38 (+0.50), DHR: 86.81 (+0.21), CMN: 44.28 (+1.09), XRAY: 52.74 (+0.32), ECL: 111.62 (+0.85)
Cantel Medical Earnings In Retrospect: Down 5.2% in the Last 19 Days (CMN)
Comtex SmarTrend(R) - Mon Dec 29, 6:54AM CST
19 days ago, on December 10th, 2014, Cantel Medical (NYSE:CMN) reported its earnings. Analysts, on average, expected earnings of $0.27 per share on sales of $137.0 million. The company actually reported EPS of $0.34 on sales of $136.8 million, beating EPS estimates by $0.07 and matching revenue estimates. Shares of Cantel Medical have slipped from $45.02 to $42.68, representing a loss of 5.2%, since the company reported earnings 19 days ago.
CMN: 44.28 (+1.09)
Medical Supplier Steris Eyes Big Returns From Buyout
at Investor's Business Daily - Mon Dec 22, 1:30PM CST
Among IBD's 197 industry groups, one of the biggest movers lately is the Medical-Systems/Equipment group, which currently ranks No. 5 after sitting as low as No. 104 six months ago. The group has gotten a lift on a few different fronts, ranging from...
ISRG: 510.73 (+3.02), BDX: 143.71 (+0.72), STE: 65.50 (-0.35), CFN: 59.81 (+0.01), OMCL: 35.29 (+0.03), CMN: 44.28 (+1.09)
Cantel Medical Shares Up 14.2% Since SmarTrend's Buy Recommendation (CMN)
Comtex SmarTrend(R) - Mon Dec 22, 9:53AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 2 months, Cantel Medical has returned 14.17% as of today's recent price of $41.53.
CMN: 44.28 (+1.09)
Cantel Medical Earnings Review: 12 Days after Announcement Shares Down 7.7% (CMN)
Comtex SmarTrend(R) - Mon Dec 22, 7:11AM CST
When Cantel Medical (NYSE:CMN) reported earnings a week ago on December 10th, 2014, analysts, on average, expected the company to report earnings of $0.27 on sales of $137.0 million. Cantel Medical actually reported earnings of $0.34 per share on sales of $136.8 million, beating EPS estimates by $0.07 and matching revenue estimates. Shares of Cantel Medical have slipped from $45.02 to $41.56, representing a loss of 7.7%, since the company reported earnings 12 days ago.
CMN: 44.28 (+1.09)
Sterilization Equipment and Supplies - 2014 Global Strategic Business Report: Growing Health Concerns Spur Demand
M2 - Thu Dec 18, 4:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/pcrkrm/sterilization) has announced the addition of the "Sterilization Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Sterilization Equipment and Supplies in US$ Million by the following Product Segments: - Filtration Sterilization - Heat Sterilization - Low Temperature Sterilization - Radiation Sterilization The report profiles 99 companies including many key and niche players such as: - 3M Company - Advanced Sterilization Products - Belimed AG - Cantel Medical Corp. - Cardinal Health, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers And Market Trends 3. End-Use Application Overview 4. Product Overview 5. Product Introductions And Launches 6. Recent Industry Activity 7. Focus On Select Global Players 8. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 99 (including Divisions/Subsidiaries 114) - The United States (53) - Canada (5) - Japan (6) - Europe (39) - France (1) - Germany (13) - The United Kingdom (9) - Italy (7) - Spain (3) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (9) - Latin America (2) For more information visit http://www.researchandmarkets.com/research/pc...rilization
MMM: 165.94 (+0.03), CAH: 86.08 (+0.04), CMN: 44.28 (+1.09)
Uptrend Call Working As Cantel Medical Stock Rises 20.1% (CMN)
Comtex SmarTrend(R) - Mon Dec 15, 9:25AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 2 months, Cantel Medical has returned 20.11% as of today's recent price of $43.69.
CMN: 44.28 (+1.09)
Cantel Medical Subsidiary Mar Cor Purification Releases New & Improved MINNCARE DRY FOG® 2 Cleanroom Bio-Decontamination System
PR Newswire - Wed Feb 04, 12:46PM CST
Mar Cor Purification, Inc. (Mar Cor), a subsidiary of Cantel Medical Corp. (NYSE: CMN) has launched a new aerosol-based bio-decontamination system, the MINNCARE DRY FOG® 2, the latest evolution of Mar Cor's Dry Fog Technology and an integral part of modern clean room disinfection procedures. Aimed specifically at the cleanroom industry, the new and improved system is designed completely of 316 L stainless steel and features a robust construction that is engineered to be durable and virtually maintenance free. The new design also features a multi-directional spray apparatus that allows for eight different nozzle(s) positions increasing the coverage possibilities for higher flexibility.
CMN: 44.28 (+1.09)
Cantel Medical's MINNCARE HD Disinfectant Wins FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 1:10PM CST
Mar Cor Purification, Inc., a subsidiary of Cantel Medical Corp. (CMN), recently received approval from the FDA for its MINNCARE HD high level disinfectant
ABMD: 60.39 (+0.46), INGN: 33.53 (+2.32), CMN: 44.28 (+1.09), SURG: 4.44 (-0.02)
Sterilization Technologies - A 2015 Global Market Overview of the $9.5 Billion Market
M2 - Wed Jan 21, 5:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/4j5x5l/sterilization) has announced the addition of the "Sterilization Technologies - A Global Market Overview" report to their offering. Global sterilization market is expected to touch US$5.3 billion 2015 and projected to touch US$9.5 billion in 2020, growing by a CAGR of 12% between 2014 and 2020. Filtration estimated the leading technology for sterilization in 2014 with US$2.7 billion and expected to touch US$3.1 billion 2015 while Medical Devices is the largest application area with market worth US$3 billion in 2014. Growing and aging global population has led to more and more surgeries being performed today than ever before. Therefore, maintaining patient safety assumes extreme criticality in the field of surgery and rules and regulations have to be in place for every aspect of the process for ensuring that errors are averted at all costs. As a consequence, disinfection and sterilization of surgical instruments becomes one area of crucial significance for upholding patient safety. This factor has a direct correlation with an increase in demand for sterilization equipment. Given the fact that every hospital and healthcare facility gives paramount importance to patient safety, sterilization techniques are most widely utilized for medical device applications. This report reviews, analyses and projects the Sterilization technologies market for global and the regional markets including the United States, Europe, Asia-Pacific and Rest of World. Global market for sterilization technologies is projected to touch $9.5 billion by 2020 growing at a decent rate compounded annually at 12% for the period 2014-2020. The United States leads the global market with a share of 29% closely followed by Europe with 27%, during 2014-2020, converting to US$1.4 billion and 1.3 billion respectively in 2014. Worldwide market for sterilization technologies explored in this study includes Chemical Sterilization, Heat Sterilization, Filtration Sterilization and Radiation Sterilization. The report also analyzes the market by application comprising Medical Devices, Pharmaceuticals, Life Sciences and Others. The global market for the above mentioned technologies and applications is analyzed in terms of USD. Key Topics Covered: Part A: Global Market Perspective 1. Introduction 2. Sterilization Applications - A Snapshot 3. Key Market Trends 4. Key Global Players 5. Key Business Trends 6. Global Market Overview Part B: Regional Market Perspective Regional Market Overview 1. The United States 2. Europe 3. Asia-Pacific 4. Rest Of World Part C: Guide To The Industry 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part
Annexure 1. Research Methodology 2. Feedback Executive Summary: - 3M Company - Advanced Sterilization Products - Andersen Products, Inc. - Baumer SA - Belimed AG - Cantel Medical Corp. - Getinge AB - Medline Industries, Inc - Nordion, Inc. - Sakura Seiki Co Ltd - Sterigenics International Inc. - Sterile Technologies, Inc. - Steris Corporation - Synergy Health Plc - TSO3 Inc. - Tuttnauer USA Co Ltd For more information visit http://www.researchandmarkets.com/research/4j...rilization MMM: 165.94 (+0.03), NDZ: 12.99 (-0.01), CMN: 44.28 (+1.09)
Love Of Pets, Trips To Vets Lift Idexx Laboratories
at Investor's Business Daily - Thu Jan 15, 5:41PM CST
Francis Pulizzi wouldn't think of scrimping on his pets' health care, even if it's a bit pricey. The New York City native and owner of three Chihuahuas figures that he spends a minimum of $300 each time he takes one of the dogs to the veterinarian. A...
ISRG: 510.73 (+3.02), STE: 65.50 (-0.35), IDXX: 159.08 (+1.72), CMN: 44.28 (+1.09)
Cantel Medical Subsidiary Mar Cor Purification Given 510(k) Clearance For MINNCARE® HD Disinfectant For Use In Water System Disinfection In Kidney Dialysis Applications
PR Newswire - Thu Jan 15, 3:16PM CST
Mar Cor Purification, Inc. (Mar Cor), a subsidiary of Cantel Medical Corp. (NYSE:CMN) announced today that it has been given 510(k) clearance (K133724) from the FDA for MINNCARE® HD high level disinfectant, the first water system disinfectant granted a medical device clearance for use in hemodialysis applications. MINNCARE HD disinfectant is a proprietary blend of peracetic acid and hydrogen peroxide and is completely biodegradable allowing for easy disposal and reducing environmental impact. The non-medical device version, MINNCARE® Cold Sterilant, is considered the gold standard in water system disinfection and is used daily in a variety of markets and applications.
CMN: 44.28 (+1.09)
Cantel Medical on a Buyout Spree, Adds Pure Water Solutions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 07, 1:10PM CST
Cantel Medical Corp (CMN) recently acquired water purification and treatment service provider Pure Water Solutions for $11.9 million in cash.
FMS: 36.43 (-0.65), CMN: 44.28 (+1.09), XRAY: 52.74 (+0.32), ECL: 111.62 (+0.85)
Cantel Medical To Present At The 33rd Annual J.P. Morgan Healthcare Conference
PR Newswire - Tue Jan 06, 10:00AM CST
CANTEL MEDICAL CORP. (NYSE:CMN) announced today that Andrew A. Krakauer, Chief Executive Officer, will be presenting at the 33rd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. The formal presentation is scheduled for Thursday, January 15, 2015 at 8:00 AM Pacific Time (11:00 AM Eastern Time). In addition, Mr. Krakauer, Jorgen B. Hansen, President and COO, and Seth Yellin, Senior Vice President-Corporate Development, will be available for separate one-on-one meetings during the day.
JPM: 59.67 (+0.10), CMN: 44.28 (+1.09)
In the Spotlight: New Research on Intel, Cantel, JPMorgan, American Airlines and Monsanto
PR Newswire - Mon Jan 05, 8:00AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Intel (NASDAQ: INTC), Cantel (NYSE: CMN), JPMorgan (NYSE: JPM), American Airlines (NASDAQ: AAL), and Monsanto (NYSE: MON). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
MON: 124.77 (+2.00), JPM: 59.67 (+0.10), AAL: 48.39 (+0.51), INTC: 34.36 (+0.23), CMN: 44.28 (+1.09)
Cantel Medical reports purchase of Pure Water Solutions for USD11.9m
M2 - Mon Jan 05, 6:18AM CST
Infection prevention company Cantel Medical (NYSE:CMN) said on Friday that it has acquired the assets of Pure Water Solutions for a purchase price of USD11.9m in cash.
CMN: 44.28 (+1.09)
Update: Cantel Medical Acquires Pure Water Solutions
David Zanoni - at Seeking Alpha - Sun Jan 04, 1:51AM CST
CMN: 44.28 (+1.09)
11 Best Mid-Cap Health Care Stocks Worth Targeting for 2015
at The Street - Fri Jan 02, 1:43PM CST
Which mid-cap health care companies should you target for the best returns? Click through to see which stocks are top-rated.
ACHC: 63.20 (-0.45), SIRO: 91.06 (+0.18), WST: 51.35 (+0.57), USPH: 41.08 (+0.07), ATRI: 332.77 (-2.85), STE: 65.50 (-0.35), GB: 50.86 (+0.20), TFX: 112.07 (+0.47), ICLR: 60.01 (+0.38), CMN: 44.28 (+1.09), UTMD: 58.02 (-0.40)
Cantel Med buys water purification and treatment firm
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 8:40AM CST
CMN: 44.28 (+1.09)
Cantel Medical Acquires Pure Water Solutions, Inc.
PR Newswire - Fri Jan 02, 7:30AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) today announced that it acquired the assets of Pure Water Solutions, Inc. for a purchase price of $11.9 million in cash consideration. Headquartered in Ridgeland, Mississippi, Pure Water Solutions provides water purification and treatment services for commercial and industrial, laboratory and medical customers out of eight regional offices throughout the Southeastern United States. The company had pre-acquisition unaudited revenues and EBITDA of just over $8 million and $2 million, respectively, for the trailing twelve months. This transaction is expected to be neutral to Cantel's GAAP EPS in FY15 and slightly accretive to its non-GAAP1 EPS in FY15, and is expected to be accretive on both a GAAP and non-GAAP[1] basis thereafter.
CMN: 44.28 (+1.09)
Cantel Medical - Great Prospects And Track Record, As The Valuation Becomes Too Steep
The Value Investor - at Seeking Alpha - Thu Jan 01, 10:10AM CST
BCR: 175.38 (+0.50), DHR: 86.81 (+0.21), CMN: 44.28 (+1.09), XRAY: 52.74 (+0.32), ECL: 111.62 (+0.85)
Cantel Medical Earnings In Retrospect: Down 5.2% in the Last 19 Days (CMN)
Comtex SmarTrend(R) - Mon Dec 29, 6:54AM CST
19 days ago, on December 10th, 2014, Cantel Medical (NYSE:CMN) reported its earnings. Analysts, on average, expected earnings of $0.27 per share on sales of $137.0 million. The company actually reported EPS of $0.34 on sales of $136.8 million, beating EPS estimates by $0.07 and matching revenue estimates. Shares of Cantel Medical have slipped from $45.02 to $42.68, representing a loss of 5.2%, since the company reported earnings 19 days ago.
CMN: 44.28 (+1.09)
Medical Supplier Steris Eyes Big Returns From Buyout
at Investor's Business Daily - Mon Dec 22, 1:30PM CST
Among IBD's 197 industry groups, one of the biggest movers lately is the Medical-Systems/Equipment group, which currently ranks No. 5 after sitting as low as No. 104 six months ago. The group has gotten a lift on a few different fronts, ranging from...
ISRG: 510.73 (+3.02), BDX: 143.71 (+0.72), STE: 65.50 (-0.35), CFN: 59.81 (+0.01), OMCL: 35.29 (+0.03), CMN: 44.28 (+1.09)
Cantel Medical Shares Up 14.2% Since SmarTrend's Buy Recommendation (CMN)
Comtex SmarTrend(R) - Mon Dec 22, 9:53AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 2 months, Cantel Medical has returned 14.17% as of today's recent price of $41.53.
CMN: 44.28 (+1.09)
Cantel Medical Earnings Review: 12 Days after Announcement Shares Down 7.7% (CMN)
Comtex SmarTrend(R) - Mon Dec 22, 7:11AM CST
When Cantel Medical (NYSE:CMN) reported earnings a week ago on December 10th, 2014, analysts, on average, expected the company to report earnings of $0.27 on sales of $137.0 million. Cantel Medical actually reported earnings of $0.34 per share on sales of $136.8 million, beating EPS estimates by $0.07 and matching revenue estimates. Shares of Cantel Medical have slipped from $45.02 to $41.56, representing a loss of 7.7%, since the company reported earnings 12 days ago.
CMN: 44.28 (+1.09)
Sterilization Equipment and Supplies - 2014 Global Strategic Business Report: Growing Health Concerns Spur Demand
M2 - Thu Dec 18, 4:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/pcrkrm/sterilization) has announced the addition of the "Sterilization Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Sterilization Equipment and Supplies in US$ Million by the following Product Segments: - Filtration Sterilization - Heat Sterilization - Low Temperature Sterilization - Radiation Sterilization The report profiles 99 companies including many key and niche players such as: - 3M Company - Advanced Sterilization Products - Belimed AG - Cantel Medical Corp. - Cardinal Health, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers And Market Trends 3. End-Use Application Overview 4. Product Overview 5. Product Introductions And Launches 6. Recent Industry Activity 7. Focus On Select Global Players 8. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 99 (including Divisions/Subsidiaries 114) - The United States (53) - Canada (5) - Japan (6) - Europe (39) - France (1) - Germany (13) - The United Kingdom (9) - Italy (7) - Spain (3) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (9) - Latin America (2) For more information visit http://www.researchandmarkets.com/research/pc...rilization
MMM: 165.94 (+0.03), CAH: 86.08 (+0.04), CMN: 44.28 (+1.09)
Uptrend Call Working As Cantel Medical Stock Rises 20.1% (CMN)
Comtex SmarTrend(R) - Mon Dec 15, 9:25AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on October 10th, 2014 at $36.38. In approximately 2 months, Cantel Medical has returned 20.11% as of today's recent price of $43.69.
CMN: 44.28 (+1.09)
